FundLens
27
Pharma & HealthcareAvoid

Tata India Pharma & Healthcare

Tata · Direct–Growth · rank #18 / 19 Smart Score ke hisaab se

Data updated

Tata India Pharma & Healthcare ka score 27/100 hai — 19 mein #18 Pharma & Healthcare fund (Avoid). Kamzori: 3 saal ka return (category mein 13th percentile).

Trailing returns

index ke muqable: Nifty 500 (index-fund proxy)
1 saal
-0.3%
+6.8% index ke muqable
3 saal
16.8%
+7.8% index ke muqable
5 saal
13.5%
+5.7% index ke muqable
Launch se
12.6%

Saal-dar-saal performance

aakhri entry = is saal ab tak
2021
20.9%
2022
-6.6%
2023
38.6%
2024
42.5%
2025
-3.5%
2026
2.3%

Risk metrics

Sharpe ratio
0.79
↑ jitna zyada, utna accha
Sortino ratio
1.15
↑ jitna zyada, utna accha
Std deviation
16.77
↓ jitna kam, utna accha
Alpha
-0.84
↑ jitna zyada, utna accha
Beta
0.99
≈1 yaani market ke saath

Isi category ke aur funds

Research aur education ke liye — investment advice nahi.